Open access · US-GOV via ClinicalTrials.gov Clinical trial

Aging Biomarkers, Geriatric Assessment and Electronic Frailty Index (AGE)

Authors not listed

Wake Forest University Health Sciences · 2022

Loss of proteostasis Human Randomized controlled trial

Abstract

The purpose of this research study is to compare methods to help personalize the prediction of chemotherapy side effects for older adults and to evaluate whether chemotherapy causes changes in the body that are associated with aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

Anonymous. (2022). Aging Biomarkers, Geriatric Assessment and Electronic Frailty Index (AGE). <em>Wake Forest University Health Sciences</em>. https://clinicaltrials.gov/study/NCT05268991

Vancouver

Anonymous. Aging Biomarkers, Geriatric Assessment and Electronic Frailty Index (AGE). Wake Forest University Health Sciences. 2022.

BibTeX

@misc{anon2022AgingB, title = {Aging Biomarkers, Geriatric Assessment and Electronic Frailty Index (AGE)}, author = {Anonymous}, journal = {Wake Forest University Health Sciences}, year = {2022}, }